- Home
- AESI vs VIR Comparison
AESI vs VIR Comparison
Compare AESI & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AESI | VIR |
|---|---|---|
| Founded | 2017 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2023 | 2019 |
Fundamental Metrics
Financial Performance| Metric | AESI | VIR |
|---|---|---|
| Price | $9.38 | $10.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 10 |
| Target Price | $17.69 | ★ $21.00 |
| AVG Volume (30 Days) | ★ 3.8M | 1.8M |
| Earning Date | 11-02-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.49 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,095,310,000.00 | $68,556,000.00 |
| Revenue This Year | $1.65 | $257.66 |
| Revenue Next Year | $17.61 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 3.73 | N/A |
| 52 Week Low | $7.64 | $4.82 |
| 52 Week High | $20.13 | $12.00 |
Technical Indicators
Market Signals| Indicator | AESI | VIR |
|---|---|---|
| Relative Strength Index (RSI) | 30.08 | 47.96 |
| Support Level | $9.40 | $10.28 |
| Resistance Level | $12.37 | $11.83 |
| Average True Range (ATR) | 0.63 | 0.62 |
| MACD | -0.28 | -0.11 |
| Stochastic Oscillator | 7.97 | 33.25 |
Price Performance
Historical ComparisonAbout AESI Atlas Energy Solutions Inc.
Atlas Energy Solutions Inc is a provider of proppant and logistics services to the oil and natural gas industry within the Permian Basin of West Texas and New Mexico, the active oil and natural gas basin in North America. Proppant is necessary to facilitate the recovery of hydrocarbons from oil and natural gas wells. One hundred percent of its sand reserves are located in Winkler and Ward Counties, Texas, within the Permian Basin, and its operations consist of proppant production and processing facilities, including two facilities near Kermit, Texas, and a third facility near Monahans, Texas.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.